MARKET

SRTS

SRTS

Sensus Hlthcr
NASDAQ

Real-time Quotes | Nasdaq Last Sale

3.810
+0.040
+1.07%
Opening 14:01 01/22 EST
OPEN
3.820
PREV CLOSE
3.770
HIGH
3.879
LOW
3.810
VOLUME
2.55K
TURNOVER
--
52 WEEK HIGH
4.990
52 WEEK LOW
1.760
MARKET CAP
62.88M
P/E (TTM)
-9.2150
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Holy Name Medical Center acquires Sensus low-dose radiation therapy system
Sensus Healthcare ([[SRTS]] +3.0%) has announced that Holy Name Medical Center has acquired a Sensus low-dose radiation therapy system for the treatment of pneumonia in COVID-19 patients."The Sensus low-dose radiation
Seekingalpha · 01/06 14:53
Holy Name Medical Center in Teaneck, New Jersey Acquires Sensus Healthcare's Low-dose Radiation Therapy System to Treat Pneumonia in COVID-19 Patients
Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, today announced Holy Name Medical Center in Te...
GlobeNewswire · 01/06 14:32
Holy Name Medical Center in Teaneck, New Jersey Acquires Sensus Healthcares Low-dose Radiation Therapy System to Treat Pneumonia in COVID-19 Patients
BOCA RATON, Fla., Jan. 06, 2021 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological condit...
GlobeNewswire · 01/06 14:32
TLRY, GLPG, IQ and MARA among midday movers
Gainers: Nxt-ID (NXTD) +50%.Diginex (EQOS) +48%.Aethlon Medical (AEMD) +40%.MIND Technology (MIND) +27%.Aclaris Therapeutics (ACRS) +24%.Tilray (TLRY) +23%.MiMedx Group (MDXG) +22%.Amyris (AMRS) +21%.Drive Shack (DS) +20%.Marathon Patent Group (MARA) +19%.Losers: Concord Medical
Seekingalpha · 12/16/2020 17:37
Tilray and MiMedx Group among healthcare gainers; BioLineRx among losers
Gainers: Aethlon Medical (AEMD) +47%. Aclaris Therapeutics (ACRS) +32%. Tilray (TLRY) +23%. MiMedx Group (MDXG) +23%. Sio Gene Therapies (SIOX) +21%.Losers: Concord Medical Services Holdings (CCM) -43%. BioLineRx (BLRX) -30%. vTv Therapeutics
Seekingalpha · 12/16/2020 16:02
Sensus Healthcare engages Ekpac Healthcare as SRT-100 distributor in China
Sensus Healthcare (SRTS) entered into a new exclusive distribution pact with Sweden based, Ekpac Healthcare to market former's SRT-100 systems in China and Hong Kong for the treatment of non-melanoma skin
Seekingalpha · 12/16/2020 10:39
Sensus Healthcare Engages Ekpac Healthcare Ltd. as New Exclusive Distributor in China for SRT-100(TM) Systems
Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces that it has entered into a new exclu...
GlobeNewswire · 12/15/2020 13:00
Sensus Healthcare Announces CMS Sets Rates Higher for SRT Reimbursement
-- Centers for Medicare & Medicaid Services sets a 66% increase in reimbursement for Radiation Treatment Delivery code 77401, and increases related Evaluation & Management codes
GlobeNewswire · 12/08/2020 13:00
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of SRTS. Analyze the recent business situations of Sensus Hlthcr through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 6 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average SRTS stock price target is 4.433 with a high estimate of 6.00 and a low estimate of 2.950.
EPS
Institutional Holdings
Institutions: 30
Institutional Holdings: 1.58M
% Owned: 9.59%
Shares Outstanding: 16.50M
TypeInstitutionsShares
Increased
5
47.94K
New
2
50.02K
Decreased
7
206.12K
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
-0.14%
Healthcare Equipment & Supplies
+0.06%
Key Executives
Chairman/President/Chief Executive Officer/Co-Founder/Director
Joseph Sardano
Co-Founder/Executive Vice President
Stephen Cohen
Chief Financial Officer
Javier Rampolla
Chief Operating Officer
Nicolas Soro
Chief Technology Officer
James Price
Vice President/General Counsel
Michael Sardano
Vice President/Director of Sales
Hoi-Bun Suen
Director
Megan Cornish
Non-Executive Director
Anthony Petrelli
Non-Executive Independent Director
John Heinrich
Non-Executive Independent Director
William McCall
Non-Executive Independent Director
Samuel O'Rear
  • Dividends
  • Splits
  • Insider Activity
No Data
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About SRTS
Sensus Healthcare, Inc. is a medical device company. The Company is focused on providing non-invasive treatments for both oncological and non-oncological skin conditions. It uses a low-energy X-ray technology known as superficial radiation therapy (SRT). The Company incorporated SRT into its portfolio of treatment devices: the SRT-100, SRT-100 Plus and SRT-100 Vision. The Company's product, the SRT-100, is a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers and other skin conditions, such as keloids. The SRT-100 treats primary lesions in the sensitive areas of the head and neck region. Its Sensus Laser Aesthetic Solutions division provides a range of in-office aesthetic dermatology procedures including facial rejuvenation, wrinkle removal, body sculpting/fat removal as well as other aesthetic applications.
More

Webull offers kinds of Sensus Healthcare Inc stock information, including NASDAQ:SRTS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SRTS stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading SRTS stock methods without spending real money on the virtual paper trading platform.